The US Food and Drug Administration (FDA) has approved an expanded indication for MED-EL’s SYNCHRONY cochlea implants in infants aged seven months and older with bilateral sensorineural hearing loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback